SITC Cancer Immunotherapy CONNECT

 

Access Scientific Highlights and More from the 32nd Annual Meeting

Review SITC's coverage from National Harbor, Md. for the 32nd Annual Meeting, visit The Sentinel, SITC's official blog, to read scientific highlights, view daily photo galleries and much more.


Read SITC 2017 Coverage

Apply for the NCI Immunotherapy Fellowship

Application Period Closes December 8

NCI_Logo.jpgSITC_Logo.jpg

Learn More

Sparkathon_Logo_PNG.png

Learn About the Awarded Projects of the SITC Sparkathon

Projects of the 2017 SITC Sparkathon have been announced! Learn more about teams TimIOs and the METIOR Incubator, and see how you can support and become involved in the efforts of these talented young investigators.

MEET THE Entire 2017 COHORT

sitc_log_white.png

Bookmark The Sentinel, SITC's New Official Blog

The Society for Immunotherapy of Cancer (SITC) is excited to announce the launch of its official blog, The Sentinel! Dedicated to providing SITC members a voice to share their expertise, The Sentinel will feature informational posts for the entire cancer immunotherapy community – from patients to clinicians to researchers.

Learn More

sitc-connect-ed-cmyk_FINAL.png

New to SITC connectED: Advances in Cancer Immunotherapy™ 2017 Video Series

Now in the SITC connectED Class Catalog, register for the Advances in Cancer Immunotherapy™ 2017 Video Series. This free online class will facilitate understanding of the clinical applications of immunotherapy for disease states with FDA-approved treatments, strategies for overcoming operational and reimbursement barriers and much more.

Register for the Class

SITC-blk.png

The Authoritative Cancer Immunotherapy Reference

SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*

member-ribbon-v4.png*Available only when ordering from Demos Medical Publishing. Cannot be combined with any other offers.

Learn More

Clinical Advances in Cancer Immunotherapy Online Portal

In partnership with Medscape Oncology, SITC offers a robust online learning portal designed to provide clinical oncologists with free, CME-/CE-certified education in the immunotherapy field.

Learn More

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • It was great seeing old friends again and meeting new ones at the 32 nd Annual Meeting & Pre-Conference Programs in National Harbor! We appreciate all who joined SITC for our most successful Annual Meeting yet and hope you had a great time learning, ...

  • The cited 2017 case report states " The restoration of the cellular immune response against tumor cells through PD-1 blockade and CRLA-4 blockade  have recently been shown to be associated with increased survival in metastatic RCC developed from native ...

  • This is an interesting subject to me since a few years back we published a study in the American Journal of Transplantation that showed blocking mTOR with a low dose of rapamycin enhanced anti-tumor activity while suppressed  allogeneic response in ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

Publications & Resources

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More